cyclopentane has been researched along with Basal Ganglia Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HABERMANN, H | 1 |
| GRUNTHAL, E | 2 |
| HARTMANN, K | 1 |
| BEHREND, RC | 1 |
| GOKAY, FK; TUKEL, K | 1 |
6 other study(ies) available for cyclopentane and Basal Ganglia Diseases
| Article | Year |
|---|---|
Experience with the new preparation Parpanit in the treatment of diseases of the extrapyramidal motor system.
Topics: Basal Ganglia Diseases; Cyclopentanes; Syndrome | 1948 |
About Parpanit, a new substance that influences extrapyramidal movement disorders.
Topics: Basal Ganglia Diseases; Cyclopentanes; Extrapyramidal Tracts; Humans | 1947 |
Clinical experience in treating extrapyramidal disorders with a new agent, parpanit.
Topics: Basal Ganglia Diseases; Cyclopentanes; Extrapyramidal Tracts; Humans | 1947 |
[Parpanit therapy of extrapyramidal disorders].
Topics: Basal Ganglia Diseases; Cyclopentanes; Parkinsonian Disorders | 1951 |
[Parpanit in therapy of extrapyramidal diseases].
Topics: Basal Ganglia Diseases; Cyclopentanes; Extrapyramidal Tracts; Humans | 1951 |
[Scientific raisins from 125 years SMW (Swiss Medical Weekly). On Parpanit, a new agents which modifies extrapyramidal motor disorders. 1946].
Topics: Antiparkinson Agents; Basal Ganglia Diseases; Cyclopentanes; History, 20th Century; Humans | 1995 |